The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Globus Medical is gearing up for a series of product launches throughout the Musculoskeletal portfolio in the coming months of 2025.

Globus Medical currently trades at $75.69 per share and has shown little upside over the past six months, posting a middling ...

The segment’s performance is expected to have remained strong in the first quarter as well, driven by growth in ...

The company currently has its sales operations distributed across 51 counties worldwide. GMED is a #3 (Hold) on the Zacks Rank, with a VGM Score of A. Additionally, the company could be a top pick ...

Buying $1000 In GMED: If an investor had bought $1000 of GMED stock 10 years ago, it would be worth $2,782.28 today based on a price of $71.01 for GMED at the time of writing.

Globus Medical GMED +0.38% Get Free Report has outperformed the market over the past 10 years by 1.4% on an annualized basis ...

In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Globus Medical (GMED – Research Report), with a price target of ...

BTIG lowered the firm’s price target on Globus Medical (GMED) to $88 from $94 and keeps a Buy rating on the shares as part of a broader ...